LIBRETTO-531, a phase 3 trial, was designed to establish the optimal first-line...
The KRYSTAL-7 study, presented at the ESMO Congress 2023, holds substantial...
In this conversation at the ESMO Congress 2023 in Madrid, Mariana Brandão, a...
Prof Nicolas Girard, Director of Medical Oncology at Institut Curie in Paris,...
The research of Dr Natasha Honoré, medical oncologist at UC Louvain, Brussels...
Prof Christine Gennigens, a medical oncologist at CHU de Liège, and Prof Els...
Dr. Michiel Strijbos, a medical oncologist at GZA Wilrijk, and Dr. Peter...
Professor Elleke Dresen of UZ Leuven (Belgium) delivered a presentation at ESMO...
Prof Hans Prenen, medical oncologist at UZA in Antwerp, delivered a lecture...
The KEYNOTE-177 trial, renowned in the medical community, delves into the...